Epstein-Barr virus infection after stem cell transplantation: new concepts are needed both for the donor and the recipient.
Bitan
Menachem
M
D000818:Animals; D016572:Cyclosporine / Q000627:therapeutic use; D020031:Epstein-Barr Virus Infections / Q000150:complications* / Q000188:drug therapy; D007244:Infectious Mononucleosis / Q000209:etiology; D012307:Risk Factors; D033581:Stem Cell Transplantation / Q000009:adverse effects*; D014019:Tissue Donors; D014180:Transplantation
D016572:Cyclosporine